Alon Ben-Noon

Alon Ben-Noon is the Co-Founder and CEO of NeuroSense Therapeutics. Alon was previously the founder and owner of MediCan Consulting, a boutique consultancy firm which provided management and project management services for Pharmaceutical and Biotech companies.

Ben-Noon began their career in project management at Teva Pharmaceuticals in 2010. Alon quickly rose through the ranks and was promoted to PM at Perrigo in 2009.

At NeuroSense Therapeutics, Ben-Noon is responsible for the company's overall vision and strategy. Alon has led the company to success by developing innovative work methodologies and providing continuity and consistency in results. Under their leadership, NeuroSense Therapeutics has become a leader in the development of new treatments for neurological disorders.

Alon Ben-Noon has a Master of Business Administration (MBA) from Ben-Gurion University of the Negev and a BSc. in Industrial Engineering from the same school. Alon also has Lahav Executive Education from Tel-Aviv University.

Avital Pushett - Head of ALS Clinical Program, Oron Yacoby-Zeevi - Chief Scientific Officer, and Or Eisenberg - CFO report to Alon Ben-Noon.